Concepedia

Fanliang Meng

FM

Statistics

Publications

5

Citations

149

H-Index

5

Active since

2017

Affiliations

Southern Medical University(Current)

Nanfang Hospital

Dalian Medical University

Second Affiliated Hospital of Chongqing Medical University

Chongqing Medical University

Fanliang Meng is an author at Southern Medical University specializing in oncology, molecular oncology, and ovarian cancer.

Publications per year

2017–2025

5

Publications

5

Roflumilast restores cAMP/PKA/CREB signaling axis for FtMt-mediated tumor inhibition of ovarian cancer

Shipeng Gong, Yongning Chen, Fanliang Meng et al. · Oncotarget · 2017 · 45 citations · Full text

, , +17

TMED2 promotes epithelial ovarian cancer growth

Chunlin Chen, Huan Wu, Fanliang Meng et al. · Oncotarget · 2017 · 29 citations · Full text

, , +11

Roflumilast enhances cisplatin‐sensitivity and reverses cisplatin‐resistance of ovarian cancer cells via <scp>cAMP</scp>/<scp>PKA</scp>/<scp>CREB</scp>‐FtMt signalling axis

Shipeng Gong, Yongning Chen, Fanliang Meng et al. · Cell Proliferation · 2018 · 28 citations · Full text

, , +15

Photodynamic gel-bombs enhance tumor penetration and downstream synergistic therapies

Fanliang Meng, Xuejiao Wang, Linyun He et al. · Signal Transduction and Targeted Therapy · 2025 · 25 citations · Full text

, , +17

RCC2, a regulator of the RalA signaling pathway, is identified as a novel therapeutic target in cisplatin‐resistant ovarian cancer

Shipeng Gong, Yongning Chen, Fanliang Meng et al. · The FASEB Journal · 2019 · 22 citations

, , +17

1–5 of 5